1. Progress in neoadjuvant therapy for gastric cancer.
- Author
-
Su, Peng-Fei and Yu, Jian-Chun
- Subjects
- *
STOMACH cancer , *NEOADJUVANT chemotherapy , *CHEMORADIOTHERAPY , *CANCER treatment , *TUMOR classification , *TREATMENT effectiveness , *RECTAL cancer - Abstract
Gastric cancer is one of the most common malignant tumor types in the world and the majority of patients have already reached the advanced stage at the time of initial diagnosis, owing to the subtle symptoms of gastric cancer in the early stage and the low rate of screening in the population. Surgical resection is one of the main treatments for advanced gastric cancer; however, the efficacy of surgery is limited by factors such as low radical resection rate and high distant metastasis rate. A large number of clinical trials have indicated that neoadjuvant therapy (NAT), which consists of neoadjuvant chemotherapy, neoadjuvant chemoradiotherapy and NAT combined with targeted therapy, may improve the therapeutic effect and prognosis of patients to different degrees. However, the benefit of NAT remains controversial due to the heterogeneity of clinical trials and gastric cancer itself. The present review summarizes the main research progress and key breakthrough of NAT for advanced gastric cancer and discusses its prospects. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF